QS Batterymarch Financial Management’s Dr. Reddy's Laboratories RDY Stock Holding History

QS Batterymarch Financial Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$353K	Hold	33,500	–	–	0.01%	619
2014 Q2	$290K	Sell	33,500 -45,000	-57%	-$378K	0.01%	638
2014 Q1	$690K	Buy	78,500 +45,000	+134%	+$391K	0.01%	699
2013 Q4	$275K	Sell	33,500 -129,500	-79%	-$1.02M	0.01%	805
2013 Q3	$1.23M	Sell	163,000 -821,500	-83%	-$5.98M	0.03%	587
2013 Q2	$7.45M	Buy	+984,500	New	+$7.19M	0.14%	192

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

QS Batterymarch Financial Management's RDY Position: Q3 2014 in Review

QS Batterymarch Financial Management held its Dr. Reddy's Laboratories (RDY) position steady in Q3 2014 at 33,500 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #619.

QS Batterymarch Financial Management first reported a position in RDY in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.45M in Q2 2013. 159 funds tracked by Wall St. Rank hold RDY as of Q3 2014.

QS Batterymarch Financial Management held 33,500 shares of Dr. Reddy's Laboratories worth $353K as of Q3 2014.
QS Batterymarch Financial Management left its Dr. Reddy's Laboratories share count unchanged in Q3 2014.
Dr. Reddy's Laboratories made up 0.01% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #619 holding.
QS Batterymarch Financial Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 6 quarters since.
QS Batterymarch Financial Management's Dr. Reddy's Laboratories position peaked at $7.45M in Q2 2013.
159 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.